Europe’s medical devices industry saw a rise of 13.04% in cross border deal activity during March 2022, when compared with the last 12-month average, led by Angelus Sano Fund, Segulah Medical Acceleration and Waha Capital’s $49m private equity deal with Signifier Medical Technology, according to GlobalData’s deals database.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all
  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

A total of 26 medical devices industry cross border deals worth $168.3m were announced for the region in March 2022, against the 12-month average of 23 deals.

Of all the deal types, M&A saw most activity in March 2022 with 14 transactions, representing a 53.9% share for the region.

In second place was venture financing with seven deals, followed by private equity deals with five transactions, respectively capturing a 26.9% and 19.2% share of the overall cross border deal activity for the month.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

In terms of value of cross border deals, private equity was the leading category in Europe’s medical devices industry with $106.62m, while M&A and venture financing deals totalled $35.15m and $26.48m, respectively.

Europe medical devices industry cross border deals in March 2022: Top deals

The top five medical devices cross border deals accounted for 84.3% of the overall value during March 2022.

The combined value of the top five medical devices cross border deals stood at $141.77m, against the overall value of $168.3m recorded for the month.

The top five medical devices industry cross border deals of March 2022 tracked by GlobalData were:

1) Angelus Sano Fund,Segulah Medical Acceleration and Waha Capital $49m private equity deal with Signifier Medical Technology

2) The $36.42m private equity of ITM Isotopen Technologien Munchen by Indigenous Critical Infrastructure Fund Canada (ICIF) and Portland Investment Counsel

3) BioKey and ImmunoPrecise Netherlands $21.94m acquisition deal with BioClue and BioStrand

4) The $21.2m private equity of Renalytix AI by Heights Capital Ireland

5) SD Biosensor $13.2m acquisition deal with bestbion dx